| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.695 | 0.001 | 0.695 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.062 0.001 DBMET00499 0.037 0.002 DBMET00498 | ||
| 0.675 | 0.003 | 0.675 | Cyclin B1 inhibitor | 0.274 0.004 DBMET00499 | ||
| 0.65 | 0.003 | 0.65 | Cyclin B2 inhibitor | 0.25 0.004 DBMET00499 | ||
| 0.637 | 0.004 | 0.637 | Cyclin-dependent kinase 1 inhibitor | 0.308 0.011 DBMET00499 | ||
| 0.603 | 0.003 | 0.603 | DNA polymerase I inhibitor | 0.444 0.005 DBMET00499 0.17 0.039 DBMET00498 | ||
| 0.598 | 0.003 | 0.598 | Cyclin B inhibitor | 0.231 0.004 DBMET00499 | ||
| 0.552 | 0.004 | 0.552 | CDK1/cyclin B inhibitor | 0.094 0.027 DBMET00499 | ||
| 0.533 | 0.009 | 0.533 | RNA-directed DNA polymerase inhibitor | 0.473 0.012 DBMET00499 0.337 0.026 DBMET00498 0.331 0.026 DB11100 | ||
| 0.51 | 0.013 | 0.51 | DNA synthesis inhibitor | 0.416 0.02 DBMET00499 0.279 0.051 DBMET00498 0.25 0.066 DB11100 | ||
| 0.478 | 0.032 | 0.478 | GABA C receptor rho-3 antagonist | 0.454 0.04 DBMET00499 0.378 0.072 DBMET00498 0.274 0.134 DB11100 | ||
| 0.406 | 0.004 | 0.406 | CDK1/cyclin B1 inhibitor | 0.093 0.031 DBMET00499 0.062 0.058 DBMET00498 | ||
| 0.392 | 0.004 | 0.392 | Check point kinase 2 inhibitor | 0.089 0.075 DBMET00499 | ||
| 0.427 | 0.05 | 0.556 | Toll-Like receptor agonist | 0.556 0.023 DBMET00499 | DBMET00499 | |
| 0.379 | 0.01 | 0.379 | Glycogen synthase kinase-3 inhibitor | 0.187 0.034 DBMET00499 | ||
| 0.433 | 0.074 | 0.473 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.473 0.047 DBMET00499 0.344 0.158 DBMET00498 0.405 0.096 DB11100 | DBMET00499 | |
| 0.409 | 0.056 | 0.566 | Toll-Like receptor 7 agonist | 0.566 0.021 DBMET00499 | DBMET00499 | |
| 0.357 | 0.005 | 0.397 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.397 0.005 DBMET00499 0.121 0.027 DB11100 | DBMET00499 | |
| 0.345 | 0.005 | 0.345 | Nitric-oxide synthase stimulant | 0.277 0.018 DBMET00499 0.206 0.079 DBMET00498 | ||
| 0.348 | 0.01 | 0.348 | Glycogen synthase kinase-3 beta inhibitor | 0.178 0.034 DBMET00499 | ||
| 0.342 | 0.005 | 0.354 | Adenosine A1 receptor antagonist | 0.354 0.005 DBMET00499 0.112 0.021 DBMET00498 | DBMET00499 | |
| 0.356 | 0.023 | 0.476 | EphB2 antagonist | 0.476 0.009 DBMET00499 | DBMET00499 | |
| 0.338 | 0.008 | 0.338 | CDK/cyclin complex inhibitor | |||
| 0.314 | 0.009 | 0.314 | GABA C receptor agonist | 0.26 0.013 DBMET00499 0.257 0.013 DBMET00498 0.177 0.025 DB11100 | ||
| 0.334 | 0.03 | 0.734 | Cyclic AMP phosphodiesterase inhibitor | 0.734 0.003 DBMET00499 0.291 0.045 DBMET00498 | DBMET00499 | |
| 0.307 | 0.003 | 0.307 | Folate antagonist | |||
| 0.31 | 0.009 | 0.509 | Bronchodilator | 0.509 0.004 DBMET00499 | DBMET00499 | |
| 0.308 | 0.01 | 0.431 | Ribosomal protein S6 kinase inhibitor | 0.431 0.005 DBMET00499 | DBMET00499 | |
| 0.291 | 0.005 | 0.291 | MAP kinase 3 inhibitor | 0.176 0.037 DBMET00499 | ||
| 0.299 | 0.015 | 0.299 | Growth factor agonist | |||
| 0.275 | 0.005 | 0.347 | Check point kinase 1 inhibitor | 0.347 0.005 DBMET00499 0.06 0.059 DBMET00498 0.121 0.02 DB11100 | DBMET00499 | |
| 0.279 | 0.01 | 0.408 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.408 0.005 DBMET00499 | DBMET00499 | |
| 0.269 | 0.005 | 0.311 | Phosphodiesterase 7B inhibitor | 0.311 0.004 DBMET00499 | DBMET00499 | |
| 0.271 | 0.01 | 0.556 | Xanthine oxidase inhibitor | 0.306 0.007 DBMET00499 0.556 0.003 DBMET00498 | DBMET00498 | |
| 0.269 | 0.008 | 0.269 | CDK2/cyclin A inhibitor | 0.115 0.046 DBMET00499 | ||
| 0.333 | 0.078 | 0.333 | Angiogenesis inhibitor | |||
| 0.259 | 0.005 | 0.259 | DNA repair enzyme inhibitor | 0.237 0.006 DBMET00499 0.199 0.009 DBMET00498 | ||
| 0.254 | 0.001 | 0.254 | Purine nucleoside phosphorylase inhibitor | 0.035 0.002 DBMET00499 0.021 0.003 DBMET00498 | ||
| 0.265 | 0.015 | 0.265 | Cyclin-dependent kinase 2 inhibitor | 0.159 0.034 DBMET00499 | ||
| 0.257 | 0.008 | 0.456 | NADH dehydrogenase inhibitor | 0.456 0.004 DBMET00499 0.223 0.009 DBMET00498 0.118 0.03 DB11100 | DBMET00499 | |
| 0.269 | 0.024 | 0.269 | Cyclin-dependent kinase inhibitor | 0.155 0.054 DBMET00499 | ||
| 0.251 | 0.007 | 0.319 | Adenosine A2 receptor antagonist | 0.319 0.005 DBMET00499 0.068 0.041 DBMET00498 | DBMET00499 | |
| 0.241 | 0.005 | 0.241 | Phenylalanine 4-hydroxylase inhibitor | 0.082 0.036 DBMET00499 0.126 0.016 DBMET00498 | ||
| 0.238 | 0.005 | 0.974 | Phosphodiesterase III inhibitor | 0.736 0.002 DBMET00499 0.974 0.001 DBMET00498 | DBMET00498 | |
| 0.235 | 0.004 | 0.235 | Myeloperoxidase inhibitor | 0.115 0.022 DBMET00499 | ||
| 0.232 | 0.002 | 0.232 | Thymidine kinase inhibitor | 0.189 0.003 DBMET00499 0.098 0.006 DBMET00498 0.037 0.035 DB11100 | ||
| 0.327 | 0.099 | 0.327 | Immunosuppressant | |||
| 0.294 | 0.068 | 0.692 | Aldehyde oxidase inhibitor | 0.692 0.009 DBMET00499 0.178 0.118 DB11100 | DBMET00499 | |
| 0.359 | 0.134 | 0.5 | DNA directed DNA polymerase inhibitor | 0.328 0.149 DBMET00499 0.5 0.082 DBMET00498 | DBMET00498 | |
| 0.254 | 0.035 | 0.254 | Src kinase inhibitor | 0.181 0.064 DBMET00499 | ||
| 0.341 | 0.123 | 0.341 | 5 Hydroxytryptamine release inhibitor | 0.243 0.238 DBMET00499 | ||
| 0.227 | 0.01 | 0.383 | Raf kinase inhibitor | 0.383 0.005 DBMET00499 | DBMET00499 | |
| 0.225 | 0.008 | 0.308 | Phosphodiesterase I inhibitor | 0.308 0.005 DBMET00499 0.12 0.027 DBMET00498 0.131 0.022 DB11100 | DBMET00499 | |
| 0.258 | 0.046 | 0.294 | Peroxidase inhibitor | 0.136 0.086 DBMET00499 0.142 0.082 DBMET00498 0.294 0.038 DB11100 | DB11100 | |
| 0.232 | 0.021 | 0.346 | Adenylate cyclase inhibitor | 0.346 0.01 DBMET00499 | DBMET00499 | |
| 0.238 | 0.027 | 0.238 | c-Src kinase inhibitor | 0.195 0.037 DBMET00499 | ||
| 0.259 | 0.055 | 0.266 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.249 0.067 DBMET00499 0.266 0.048 DBMET00498 | DBMET00498 | |
| 0.233 | 0.03 | 0.233 | Protein kinase (CK1) inhibitor | 0.149 0.068 DBMET00499 | ||
| 0.26 | 0.063 | 0.26 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.215 0.084 DBMET00499 | ||
| 0.202 | 0.007 | 0.202 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.182 0.007 DBMET00499 0.136 0.009 DBMET00498 0.064 0.031 DB11100 | ||
| 0.215 | 0.022 | 0.215 | Protein kinase (CK2) alpha inhibitor | 0.116 0.064 DBMET00499 | ||
| 0.201 | 0.009 | 0.201 | Antimetabolite | 0.191 0.01 DBMET00499 0.168 0.011 DBMET00498 0.05 0.031 DB11100 | ||
| 0.197 | 0.009 | 0.348 | Adenosine A3 receptor antagonist | 0.348 0.004 DBMET00499 0.148 0.013 DBMET00498 | DBMET00499 | |
| 0.196 | 0.01 | 0.248 | Adenosine A2a receptor antagonist | 0.248 0.007 DBMET00499 0.065 0.04 DBMET00498 | DBMET00499 | |
| 0.253 | 0.07 | 0.253 | Dyrk kinase inhibitor | 0.214 0.091 DBMET00499 | ||
| 0.189 | 0.007 | 0.189 | Cyclin B3 inhibitor | |||
| 0.186 | 0.009 | 0.2 | Argininosuccinate synthase inhibitor | 0.2 0.008 DBMET00499 0.064 0.034 DBMET00498 0.077 0.026 DB11100 | DBMET00499 | |
| 0.182 | 0.005 | 0.224 | Phosphodiesterase 4C inhibitor | 0.144 0.008 DBMET00499 0.224 0.005 DBMET00498 0.117 0.011 DB11100 | DBMET00498 | |
| 0.199 | 0.022 | 0.199 | CF transmembrane conductance regulator agonist | 0.171 0.046 DBMET00499 | ||
| 0.216 | 0.04 | 0.227 | 5 Hydroxytryptamine 3E antagonist | 0.227 0.03 DBMET00499 | DBMET00499 | |
| 0.198 | 0.029 | 0.198 | MAP kinase kinase inhibitor | 0.166 0.043 DBMET00499 | ||
| 0.171 | 0.002 | 0.171 | AICAR transformylase inhibitor | 0.147 0.003 DBMET00499 0.072 0.009 DBMET00498 | ||
| 0.168 | 0.001 | 0.168 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.133 0.001 DBMET00499 0.07 0.006 DBMET00498 0.029 0.018 DB11100 | ||
| 0.176 | 0.011 | 0.176 | Cyclin A2 inhibitor | 0.065 0.043 DBMET00499 | ||
| 0.189 | 0.025 | 0.189 | Cyclin-dependent kinase 5 inhibitor | 0.124 0.055 DBMET00499 | ||
| 0.167 | 0.003 | 0.167 | Dihydropteroate synthase inhibitor | 0.059 0.012 DBMET00498 | ||
| 0.184 | 0.026 | 0.186 | Ferrochelatase inhibitor | 0.159 0.034 DBMET00499 0.146 0.039 DBMET00498 0.186 0.026 DB11100 | DB11100 | |
| 0.26 | 0.107 | 0.439 | Immunomodulator | 0.192 0.174 DBMET00499 0.439 0.034 DBMET00498 | DBMET00498 | |
| 0.165 | 0.013 | 0.165 | Glutamate dehydrogenase inhibitor | 0.139 0.018 DBMET00499 0.081 0.043 DBMET00498 0.097 0.032 DB11100 | ||
| 0.162 | 0.012 | 0.162 | MAP kinase kinase 1 inhibitor | 0.114 0.041 DBMET00499 0.103 0.053 DBMET00498 | ||
| 0.281 | 0.134 | 0.281 | Histamine release inhibitor | 0.28 0.135 DBMET00499 | ||
| 0.181 | 0.036 | 0.181 | Protein kinase (CK1) delta inhibitor | |||
| 0.149 | 0.005 | 0.207 | Nicotinic acid receptor 1 agonist | 0.207 0.004 DBMET00499 | DBMET00499 | |
| 0.156 | 0.012 | 0.192 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.192 0.006 DBMET00499 | DBMET00499 | |
| 0.151 | 0.009 | 0.151 | mTOR complex 2 inhibitor | 0.09 0.047 DBMET00499 | ||
| 0.159 | 0.02 | 0.159 | TIE-2 antagonist | |||
| 0.151 | 0.013 | 0.151 | Cyclin A inhibitor | 0.055 0.048 DBMET00499 | ||
| 0.159 | 0.021 | 0.159 | TIE antagonist | |||
| 0.159 | 0.023 | 0.163 | Adenylate kinase inhibitor | 0.163 0.022 DBMET00499 0.122 0.042 DBMET00498 0.144 0.029 DB11100 | DBMET00499 | |
| 0.146 | 0.012 | 0.199 | Carbamoyl phosphate synthetase inhibitor | 0.199 0.007 DBMET00499 0.109 0.018 DBMET00498 0.132 0.014 DB11100 | DBMET00499 | |
| 0.153 | 0.02 | 0.153 | Telomerase inhibitor | |||
| 0.144 | 0.012 | 0.144 | Phosphatidylinositol 3-kinase delta inhibitor | 0.073 0.028 DBMET00499 | ||
| 0.15 | 0.019 | 0.15 | Phosphodiesterase 4D inhibitor | 0.138 0.022 DBMET00499 0.094 0.04 DBMET00498 0.133 0.023 DB11100 | ||
| 0.197 | 0.07 | 0.197 | Tyrosine kinase inhibitor | |||
| 0.163 | 0.037 | 0.163 | Aurora-C kinase inhibitor | |||
| 0.149 | 0.024 | 0.168 | DNA directed RNA polymerase inhibitor | 0.168 0.019 DBMET00499 0.095 0.063 DBMET00498 | DBMET00499 | |
| 0.128 | 0.003 | 0.128 | Adenosine deaminase inhibitor | 0.085 0.008 DBMET00499 0.061 0.02 DBMET00498 | ||
| 0.147 | 0.023 | 0.156 | GABA C receptor rho-1 antagonist | 0.156 0.019 DBMET00499 0.091 0.076 DBMET00498 | DBMET00499 | |
| 0.15 | 0.027 | 0.15 | CDK3/cyclin E inhibitor | |||
| 0.127 | 0.006 | 0.127 | Histamine agonist | 0.05 0.039 DBMET00499 | ||
| 0.172 | 0.051 | 0.28 | RET inhibitor | 0.28 0.026 DBMET00499 | DBMET00499 | |
| 0.154 | 0.033 | 0.154 | MAP kinase kinase kinase inhibitor | 0.112 0.056 DBMET00499 | ||
| 0.152 | 0.032 | 0.214 | Protein kinase (CK2) inhibitor | 0.214 0.016 DBMET00499 | DBMET00499 | |
| 0.127 | 0.007 | 0.973 | Phosphodiesterase 3B inhibitor | 0.266 0.004 DBMET00499 0.973 0.001 DBMET00498 | DBMET00498 | |
| 0.188 | 0.069 | 0.202 | LIM domain kinase 1 inhibitor | 0.202 0.062 DBMET00499 | DBMET00499 | |
| 0.121 | 0.004 | 0.121 | Thymidylate synthase inhibitor | 0.075 0.009 DBMET00499 0.081 0.007 DBMET00498 | ||
| 0.195 | 0.078 | 0.195 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.144 0.143 DBMET00499 | ||
| 0.152 | 0.036 | 0.152 | Death-associated protein kinase 1 inhibitor | 0.143 0.052 DBMET00498 | ||
| 0.134 | 0.017 | 0.134 | mTOR complex 1 inhibitor | 0.12 0.029 DBMET00499 | ||
| 0.134 | 0.019 | 0.487 | Phosphodiesterase 3A inhibitor | 0.185 0.01 DBMET00499 0.487 0.003 DBMET00498 | DBMET00498 | |
| 0.123 | 0.008 | 0.332 | Adenosine A2b receptor antagonist | 0.332 0.003 DBMET00499 0.045 0.04 DBMET00498 | DBMET00499 | |
| 0.218 | 0.104 | 0.218 | Interleukin agonist | |||
| 0.162 | 0.048 | 0.162 | Tyrosine-protein kinase receptor FLT3 inhibitor | |||
| 0.171 | 0.057 | 0.171 | Protein-tyrosine kinase Lyn inhibitor | 0.139 0.072 DBMET00499 | ||
| 0.13 | 0.017 | 0.142 | Alpha 2d adrenoreceptor antagonist | 0.142 0.011 DBMET00499 | DBMET00499 | |
| 0.163 | 0.05 | 0.805 | Phosphodiesterase inhibitor | 0.625 0.004 DBMET00499 0.805 0.004 DBMET00498 | DBMET00498 | |
| 0.14 | 0.027 | 0.14 | Protein kinase A inhibitor | 0.077 0.063 DBMET00499 | ||
| 0.191 | 0.079 | 0.191 | I kappa B kinase epsilon inhibitor | |||
| 0.166 | 0.055 | 0.195 | GABA C receptor rho-2 antagonist | 0.195 0.032 DBMET00499 0.14 0.087 DBMET00498 | DBMET00499 | |
| 0.144 | 0.033 | 0.152 | GABA C receptor antagonist | 0.152 0.029 DBMET00499 0.124 0.049 DBMET00498 | DBMET00499 | |
| 0.146 | 0.035 | 0.146 | Nav1.4 sodium channel blocker | |||
| 0.115 | 0.005 | 0.115 | Histamine H3 receptor agonist | 0.102 0.006 DBMET00499 | ||
| 0.12 | 0.011 | 0.295 | Xanthine dehydrogenase inhibitor | 0.154 0.007 DBMET00499 0.295 0.003 DBMET00498 | DBMET00498 | |
| 0.113 | 0.007 | 0.113 | Factor IXa inhibitor | |||
| 0.122 | 0.018 | 0.237 | Phosphodiesterase V inhibitor | 0.237 0.005 DBMET00499 0.209 0.005 DBMET00498 | DBMET00499 | |
| 0.126 | 0.023 | 0.142 | Phosphofructokinase-1 inhibitor | 0.142 0.02 DBMET00499 0.083 0.039 DBMET00498 0.074 0.045 DB11100 | DBMET00499 | |
| 0.196 | 0.093 | 0.196 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.177 0.111 DB11100 | ||
| 0.149 | 0.047 | 0.149 | Alkylator | 0.128 0.061 DBMET00499 | ||
| 0.107 | 0.005 | 0.107 | CDK5/p25 inhibitor | 0.042 0.027 DBMET00499 | ||
| 0.165 | 0.065 | 0.301 | Diuretic | 0.301 0.022 DBMET00499 | DBMET00499 | |
| 0.108 | 0.008 | 0.108 | MAP kinase kinase 7 inhibitor | 0.085 0.034 DBMET00499 0.081 0.044 DBMET00498 | ||
| 0.114 | 0.015 | 0.232 | Biliverdin reductase inhibitor | 0.232 0.004 DBMET00499 0.129 0.012 DBMET00498 0.112 0.015 DB11100 | DBMET00499 | |
| 0.143 | 0.047 | 0.296 | MAP kinase 12 inhibitor | 0.296 0.007 DBMET00499 0.166 0.034 DBMET00498 | DBMET00499 | |
| 0.106 | 0.01 | 0.106 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.078 0.04 DBMET00499 | ||
| 0.097 | 0.002 | 0.097 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.078 0.003 DBMET00499 0.047 0.004 DBMET00498 | ||
| 0.156 | 0.062 | 0.156 | Lck kinase inhibitor | 0.103 0.099 DBMET00499 | ||
| 0.117 | 0.024 | 0.117 | Hematopoietic | |||
| 0.097 | 0.004 | 0.097 | Histamine H2 receptor agonist | 0.058 0.016 DBMET00499 | ||
| 0.135 | 0.043 | 0.135 | Platelet activating factor beta antagonist | 0.085 0.075 DBMET00499 | ||
| 0.109 | 0.019 | 0.109 | CDC7 inhibitor | 0.069 0.045 DBMET00499 | ||
| 0.129 | 0.041 | 0.129 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.104 | 0.02 | 0.104 | MAP3K7 inhibitor | |||
| 0.099 | 0.016 | 0.1 | Ornithine carbamoyltransferase inhibitor | 0.1 0.016 DBMET00499 0.047 0.043 DBMET00498 0.073 0.024 DB11100 | DBMET00499 | |
| 0.119 | 0.037 | 0.123 | Electrolyte absorption antagonist | 0.113 0.043 DBMET00499 0.123 0.034 DB11100 | DB11100 | |
| 0.149 | 0.068 | 0.194 | Glycogen synthase kinase-3 alpha inhibitor | 0.194 0.043 DBMET00499 | DBMET00499 | |
| 0.215 | 0.134 | 0.215 | Hypoxia-inducible factor 1 alpha inhibitor | 0.188 0.167 DBMET00499 | ||
| 0.095 | 0.018 | 0.095 | Acyl-CoA dehydrogenase inhibitor | 0.081 0.022 DBMET00499 0.049 0.043 DBMET00498 | ||
| 0.096 | 0.02 | 0.096 | Carbonic anhydrase stimulant | 0.059 0.041 DBMET00499 | ||
| 0.2 | 0.123 | 0.2 | MAP kinase kinase 3 inhibitor | |||
| 0.191 | 0.116 | 0.223 | MAP-kinase-activated kinase 5 inhibitor | 0.223 0.08 DBMET00499 | DBMET00499 | |
| 0.112 | 0.037 | 0.112 | Interleukin 12 antagonist | |||
| 0.101 | 0.028 | 0.112 | Interferon agonist | 0.112 0.021 DBMET00498 | DBMET00498 | |
| 0.099 | 0.026 | 0.12 | Protein kinase B beta inhibitor | 0.12 0.015 DBMET00499 0.069 0.058 DBMET00498 | DBMET00499 | |
| 0.098 | 0.028 | 0.232 | Phosphodiesterase 5A inhibitor | 0.232 0.005 DBMET00499 0.211 0.005 DBMET00498 | DBMET00499 | |
| 0.096 | 0.028 | 0.096 | T cell inhibitor | |||
| 0.12 | 0.052 | 0.12 | Protein kinase C gamma inhibitor | |||
| 0.072 | 0.006 | 0.072 | Dihydrofolate reductase inhibitor | |||
| 0.096 | 0.029 | 0.096 | CDK2/cyclin E2 inhibitor | |||
| 0.085 | 0.019 | 0.085 | Phosphodiesterase 4A inhibitor | 0.085 0.019 DBMET00499 | ||
| 0.084 | 0.023 | 0.128 | Phosphodiesterase VII inhibitor | 0.128 0.005 DBMET00499 | DBMET00499 | |
| 0.082 | 0.022 | 0.096 | Interferon inducer | 0.096 0.014 DBMET00498 | DBMET00498 | |
| 0.188 | 0.128 | 0.32 | Immunostimulant | 0.159 0.147 DBMET00499 0.32 0.073 DBMET00498 | DBMET00498 | |
| 0.103 | 0.043 | 0.103 | Histamine N-methyltransferase inhibitor | 0.077 0.07 DBMET00499 | ||
| 0.062 | 0.002 | 0.062 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.007 0.006 DBMET00498 | ||
| 0.141 | 0.081 | 0.141 | MAP kinase kinase 4 inhibitor | |||
| 0.116 | 0.056 | 0.116 | Aurora-A kinase inhibitor | |||
| 0.124 | 0.065 | 0.124 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | |||
| 0.124 | 0.065 | 0.124 | Abl kinase inhibitor | |||
| 0.168 | 0.111 | 0.244 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.222 0.057 DBMET00499 0.244 0.045 DBMET00498 | DBMET00498 | |
| 0.058 | 0.004 | 0.058 | Histamine H4 receptor agonist | |||
| 0.067 | 0.014 | 0.067 | Histamine H4 receptor antagonist | |||
| 0.073 | 0.021 | 0.117 | Phosphodiesterase 1A inhibitor | 0.117 0.007 DBMET00499 0.062 0.036 DB11100 | DBMET00499 | |
| 0.066 | 0.014 | 0.067 | Alpha 1b adrenoreceptor agonist | 0.067 0.014 DBMET00499 | DBMET00499 | |
| 0.087 | 0.035 | 0.087 | Syk tyrosine kinase inhibitor | |||
| 0.175 | 0.124 | 0.175 | ErbB-1 antagonist | |||
| 0.072 | 0.022 | 0.394 | Phosphodiesterase II inhibitor | 0.117 0.008 DBMET00499 0.394 0.002 DBMET00498 | DBMET00498 | |
| 0.087 | 0.038 | 0.087 | Histidine decarboxylase inhibitor | 0.079 0.043 DBMET00499 0.074 0.047 DB11100 | ||
| 0.161 | 0.112 | 0.161 | MAP kinase kinase 5 inhibitor | |||
| 0.157 | 0.108 | 0.199 | Clk dual-specificity kinase inhibitor | 0.199 0.08 DBMET00499 | DBMET00499 | |
| 0.134 | 0.086 | 0.149 | MAP3K9 inhibitor | 0.149 0.061 DBMET00499 | DBMET00499 | |
| 0.057 | 0.01 | 0.057 | Histamine H1 receptor agonist | 0.053 0.015 DBMET00499 | ||
| 0.131 | 0.085 | 0.131 | CDC-like kinase 1 inhibitor | |||
| 0.159 | 0.113 | 0.159 | MAP kinase kinase 2 inhibitor | 0.158 0.114 DBMET00499 | ||
| 0.072 | 0.026 | 0.072 | Cyclin H inhibitor | |||
| 0.045 | 0.004 | 0.091 | DNA polymerase III inhibitor | 0.062 0.003 DBMET00499 0.091 0.002 DBMET00498 | DBMET00498 | |
| 0.08 | 0.042 | 0.08 | GABA B receptor agonist | |||
| 0.099 | 0.061 | 0.099 | Nitric-oxide synthase inhibitor | |||
| 0.06 | 0.023 | 0.06 | Carbonic anhydrase II stimulant | 0.054 0.032 DBMET00499 | ||
| 0.07 | 0.034 | 0.371 | Raf kinase B inhibitor | 0.371 0.005 DBMET00499 | DBMET00499 | |
| 0.098 | 0.062 | 0.098 | Creatine kinase inhibitor | |||
| 0.045 | 0.009 | 0.069 | Phosphodiesterase 6B inhibitor | 0.069 0.004 DBMET00499 0.069 0.004 DBMET00498 | DBMET00498 | |
| 0.049 | 0.014 | 0.058 | Fumarate hydratase inhibitor | 0.058 0.011 DBMET00499 0.033 0.026 DB11100 | DBMET00499 | |
| 0.106 | 0.071 | 0.151 | Polo-like kinase-4 inhibitor | 0.151 0.035 DBMET00499 | DBMET00499 | |
| 0.208 | 0.175 | 0.235 | Vasodilator, coronary | 0.235 0.149 DBMET00499 | DBMET00499 | |
| 0.113 | 0.08 | 0.113 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.058 | 0.025 | 0.385 | Phosphodiesterase 2A inhibitor | 0.096 0.009 DBMET00499 0.385 0.002 DBMET00498 | DBMET00498 | |
| 0.123 | 0.093 | 0.123 | Activin receptor-like kinase 2 inhibitor | |||
| 0.092 | 0.062 | 0.13 | Alcohol dehydrogenase inhibitor | 0.13 0.029 DBMET00499 | DBMET00499 | |
| 0.046 | 0.016 | 0.046 | Phosphoglycerate kinase inhibitor | 0.033 0.027 DBMET00499 | ||
| 0.05 | 0.021 | 0.074 | Phosphodiesterase 6C inhibitor | 0.064 0.006 DBMET00499 0.074 0.004 DBMET00498 | DBMET00498 | |
| 0.037 | 0.008 | 0.037 | Purinergic P2Y15 antagonist | 0.033 0.012 DBMET00499 0.028 0.02 DBMET00498 | ||
| 0.033 | 0.004 | 0.066 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.066 0.002 DBMET00499 0.034 0.004 DBMET00498 | DBMET00499 | |
| 0.049 | 0.022 | 0.105 | Glutamate (mGluR4) antagonist | 0.105 0.005 DBMET00499 | DBMET00499 | |
| 0.093 | 0.069 | 0.196 | UDP-glucose 4-epimerase inhibitor | 0.196 0.019 DBMET00499 0.116 0.046 DBMET00498 0.143 0.031 DB11100 | DBMET00499 | |
| 0.045 | 0.02 | 0.057 | Alpha 1d adrenoreceptor agonist | 0.057 0.012 DBMET00499 | DBMET00499 | |
| 0.033 | 0.01 | 0.157 | Thymidine phosphorylase inhibitor | 0.11 0.003 DBMET00499 0.157 0.002 DBMET00498 0.049 0.005 DB11100 | DBMET00498 | |
| 0.043 | 0.021 | 0.043 | MAP3K5 inhibitor | |||
| 0.062 | 0.04 | 0.062 | Alpha 2 adrenoreceptor agonist | |||
| 0.03 | 0.009 | 0.035 | Alpha 2d adrenoreceptor agonist | 0.035 0.007 DBMET00499 | DBMET00499 | |
| 0.057 | 0.038 | 0.106 | Alcohol oxidase inhibitor | 0.082 0.023 DBMET00499 0.053 0.042 DBMET00498 0.106 0.017 DB11100 | DB11100 | |
| 0.06 | 0.041 | 0.06 | Raf kinase C inhibitor | |||
| 0.023 | 0.004 | 0.023 | CDK2/cyclin A3 inhibitor | |||
| 0.041 | 0.023 | 0.041 | Diamine oxidase inhibitor | |||
| 0.036 | 0.018 | 0.036 | Potassium channel small-conductance Ca-activated activator | |||
| 0.083 | 0.066 | 0.083 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.06 | 0.043 | 0.143 | Purinergic P2X1 antagonist | 0.083 0.023 DBMET00499 0.143 0.008 DBMET00498 | DBMET00498 | |
| 0.086 | 0.069 | 0.086 | Fibroblast growth factor 1 antagonist | |||
| 0.19 | 0.173 | 0.205 | Insulysin inhibitor | 0.205 0.149 DBMET00499 | DBMET00499 | |
| 0.079 | 0.062 | 0.079 | AXL receptor tyrosine kinase inhibitor | |||
| 0.067 | 0.051 | 0.08 | Exportin-1 inhibitor | 0.08 0.025 DBMET00499 | DBMET00499 | |
| 0.063 | 0.048 | 0.063 | Fibroblast growth factor 2 antagonist | |||
| 0.098 | 0.084 | 0.098 | Vascular endothelial growth factor antagonist | |||
| 0.036 | 0.023 | 0.041 | Tryptophan 5 hydroxylase inhibitor | 0.034 0.032 DBMET00499 0.041 0.014 DBMET00498 | DBMET00498 | |
| 0.017 | 0.004 | 0.031 | DNA polymerase III polC-type inhibitor | 0.031 0.003 DBMET00499 | DBMET00499 | |
| 0.079 | 0.067 | 0.081 | Histamine H2 receptor antagonist | 0.081 0.063 DB11100 | DB11100 | |
| 0.013 | 0.003 | 0.035 | DNA polymerase III subunit alpha inhibitor | 0.018 0.002 DBMET00499 0.035 0.001 DBMET00498 | DBMET00498 | |
| 0.031 | 0.021 | 0.031 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.019 | 0.01 | 0.019 | Granulocyte colony stimulating factor receptor agonist | |||
| 0.02 | 0.011 | 0.02 | Alpha 2c adrenoreceptor agonist | |||
| 0.124 | 0.115 | 0.144 | Adenylate cyclase stimulant | 0.144 0.073 DBMET00499 0.128 0.105 DBMET00498 | DBMET00499 | |
| 0.024 | 0.015 | 0.034 | Phosphodiesterase 6A inhibitor | 0.034 0.005 DBMET00499 0.028 0.008 DBMET00498 | DBMET00499 | |
| 0.034 | 0.025 | 0.034 | Purinergic P2X3 antagonist | |||
| 0.032 | 0.024 | 0.032 | ATR kinase inhibitor | |||
| 0.11 | 0.103 | 0.11 | Growth factor antagonist | |||
| 0.019 | 0.012 | 0.019 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.015 DBMET00499 | ||
| 0.023 | 0.017 | 0.04 | Phosphodiesterase 6H inhibitor | 0.031 0.007 DBMET00499 0.04 0.004 DBMET00498 | DBMET00498 | |
| 0.023 | 0.017 | 0.04 | Phosphodiesterase 6G inhibitor | 0.031 0.007 DBMET00499 0.04 0.004 DBMET00498 | DBMET00498 | |
| 0.063 | 0.057 | 0.063 | Protein kinase B alpha inhibitor | |||
| 0.103 | 0.098 | 0.203 | Alpha-N-acetylglucosaminidase inhibitor | 0.133 0.066 DBMET00499 0.203 0.033 DBMET00498 0.159 0.05 DB11100 | DBMET00498 | |
| 0.009 | 0.004 | 0.019 | DNA topoisomerase III inhibitor | 0.011 0.003 DBMET00499 0.019 0.002 DBMET00498 0.008 0.004 DB11100 | DBMET00498 | |
| 0.017 | 0.012 | 0.017 | Tryptophan hydroxylase 1 inhibitor | |||
| 0.055 | 0.05 | 0.134 | Phosphodiesterase 1B inhibitor | 0.134 0.008 DBMET00499 0.068 0.032 DBMET00498 | DBMET00499 | |
| 0.058 | 0.053 | 0.058 | Purinergic P2X2 antagonist | |||
| 0.063 | 0.059 | 0.063 | Janus tyrosine kinase 3 inhibitor | |||
| 0.017 | 0.013 | 0.017 | Adenosine A3 receptor agonist | |||
| 0.018 | 0.015 | 0.018 | Alpha 2b adrenoreceptor agonist | |||
| 0.075 | 0.073 | 0.075 | Epidermal growth factor antagonist | |||
| 0.01 | 0.008 | 0.01 | Purinergic P2Y2 agonist | |||
| 0.049 | 0.047 | 0.049 | Bruton tyrosine kinase inhibitor | |||
| 0.02 | 0.018 | 0.031 | Glutaminyl-peptide cyclotransferase inhibitor | 0.031 0.006 DBMET00499 | DBMET00499 | |
| 0.033 | 0.032 | 0.033 | Carbonic anhydrase I stimulant | |||
| 0.04 | 0.04 | 0.055 | Glutamate (mGluR group III) antagonist | 0.055 0.016 DBMET00499 | DBMET00499 | |
| 0.063 | 0.064 | 0.072 | Porphobilinogen synthase inhibitor | 0.072 0.054 DBMET00499 | DBMET00499 | |
| 0.03 | 0.035 | 0.059 | Protein kinase (CK2) beta inhibitor | 0.059 0.005 DBMET00499 0.031 0.028 DBMET00498 0.032 0.026 DB11100 | DBMET00499 | |
| 0.009 | 0.014 | 0.024 | Egl nine homolog 2 inhibitor | 0.024 0.004 DBMET00499 | DBMET00499 | |
| 0.127 | 0.136 | 0.132 | Ca2+-transporting ATPase inhibitor | 0.13 0.122 DBMET00499 0.132 0.108 DBMET00498 | DBMET00498 | |
| 0.041 | 0.052 | 0.05 | mTOR inhibitor | 0.05 0.038 DBMET00499 | DBMET00499 | |
| 0.054 | 0.068 | 0.089 | Phosphodiesterase 1C inhibitor | 0.089 0.014 DBMET00499 0.082 0.018 DBMET00498 0.064 0.039 DB11100 | DBMET00499 | |
| 0.072 | 0.091 | 0.158 | HIV-1 integrase (Overall Integration) inhibitor | 0.158 0.022 DBMET00498 | DBMET00498 | |
| 0.09 | 0.111 | 0.13 | Nav1.3 sodium channel blocker | 0.13 0.064 DBMET00499 | DBMET00499 | |
| 0.007 | 0.029 | 0.031 | Egl nine homolog 3 inhibitor | 0.031 0.003 DBMET00499 0.025 0.004 DBMET00498 | DBMET00499 | |
| 0.112 | 0.14 | 0.262 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.262 0.044 DBMET00499 | DBMET00499 | |
| 0.077 | 0.106 | 0.097 | Granulocyte macrophage colony stimulating factor antagonist | 0.097 0.075 DBMET00499 | DBMET00499 | |
| 0.049 | 0.08 | 0.076 | Corticotropin releasing factor 2 receptor antagonist | 0.076 0.021 DBMET00499 | DBMET00499 | |
| 0.059 | 0.095 | 0.086 | Phosphodiesterase VI inhibitor | 0.086 0.033 DBMET00499 | DBMET00499 | |
| 0.02 | 0.057 | 0.082 | Nicotinic acid receptor agonist | 0.082 0.006 DBMET00499 | DBMET00499 | |
| 0.005 | 0.051 | 0.019 | Egl nine homolog 1 inhibitor | 0.018 0.006 DBMET00499 0.019 0.006 DBMET00498 | DBMET00498 | |
| 0.024 | 0.073 | 0.034 | Transforming growth factor beta 2 antagonist | 0.034 0.021 DBMET00499 | DBMET00499 | |
| 0.051 | 0.1 | 0.203 | Protein kinase B gamma inhibitor | 0.076 0.051 DBMET00499 0.203 0.008 DBMET00498 | DBMET00498 | |
| 0.088 | 0.139 | 0.117 | Protein kinase (CK1) gamma inhibitor | 0.117 0.093 DBMET00499 | DBMET00499 | |
| 0.066 | 0.117 | 0.105 | Ephrin antagonist | 0.105 0.059 DBMET00499 | DBMET00499 | |
| 0.066 | 0.119 | 0.318 | Uric acid excretion stimulant | 0.222 0.01 DBMET00499 0.318 0.005 DBMET00498 | DBMET00498 | |
| 0.205 | 0.26 | 0.31 | MAP kinase kinase 6 inhibitor | 0.31 0.126 DBMET00498 | DBMET00498 | |
| 0.163 | 0.218 | 0.215 | Tyrosine 3 hydroxylase inhibitor | 0.215 0.11 DBMET00498 0.189 0.157 DB11100 | DBMET00498 | |
| 0.05 | 0.105 | 0.191 | Phosphodiesterase IV inhibitor | 0.191 0.014 DBMET00499 0.117 0.034 DBMET00498 0.084 0.057 DB11100 | DBMET00499 | |
| 0.101 | 0.157 | 0.144 | Cyclin-dependent kinase 8 inhibitor | 0.144 0.086 DBMET00499 | DBMET00499 | |
| 0.033 | 0.089 | 0.052 | EphB4 antagonist | 0.052 0.047 DBMET00499 | DBMET00499 | |
| 0.099 | 0.157 | 0.18 | CDC-like kinase 4 inhibitor | 0.18 0.079 DBMET00499 | DBMET00499 | |
| 0.128 | 0.192 | 0.572 | Vasodilator | 0.572 0.007 DBMET00499 | DBMET00499 | |
| 0.06 | 0.126 | 0.083 | Pim-3 kinase inhibitor | 0.083 0.071 DBMET00499 | DBMET00499 | |
| 0.136 | 0.212 | 0.262 | Superoxide dismutase inhibitor | 0.195 0.123 DBMET00499 0.262 0.067 DB11100 | DB11100 | |
| 0.074 | 0.151 | 0.094 | DOPA decarboxylase inhibitor | 0.094 0.089 DBMET00498 | DBMET00498 | |
| 0.089 | 0.166 | 0.123 | Cell wall synthesis inhibitor | 0.117 0.103 DBMET00499 0.123 0.095 DB11100 | DB11100 | |
| 0.109 | 0.188 | 0.165 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.165 0.099 DBMET00499 | DBMET00499 | |
| 0.029 | 0.11 | 0.044 | Glucose-6-phosphate isomerase inhibitor | 0.044 0.04 DBMET00498 | DBMET00498 | |
| 0.015 | 0.096 | 0.026 | Acid ceramidase inhibitor | 0.026 0.017 DBMET00499 | DBMET00499 | |
| 0.051 | 0.134 | 0.095 | Aminopeptidase B inhibitor | 0.095 0.069 DB11100 | DB11100 | |
| 0.079 | 0.17 | 0.194 | Cytidine deaminase inhibitor | 0.155 0.072 DBMET00499 0.194 0.05 DBMET00498 | DBMET00498 | |
| 0.057 | 0.149 | 0.086 | Triose-phosphate isomerase inhibitor | 0.086 0.065 DB11100 | DB11100 | |
| 0.026 | 0.118 | 0.049 | Kainate receptor agonist | 0.039 0.035 DBMET00498 0.049 0.014 DB11100 | DB11100 | |
| 0.06 | 0.153 | 0.12 | 5 Hydroxytryptamine 3A agonist | 0.12 0.055 DB11100 | DB11100 | |
| 0.03 | 0.127 | 0.118 | HIV-1 reverse transcriptase inhibitor | 0.118 0.023 DBMET00498 | DBMET00498 | |
| 0.111 | 0.207 | 0.161 | Succinate dehydrogenase inhibitor | 0.161 0.093 DBMET00498 | DBMET00498 | |
| 0.058 | 0.157 | 0.115 | M18 aspartyl aminopeptidase inhibitor | 0.115 0.075 DBMET00499 | DBMET00499 | |
| 0.198 | 0.297 | 0.458 | MAP kinase 1 inhibitor | 0.25 0.233 DBMET00499 0.458 0.073 DBMET00498 | DBMET00498 | |
| 0.015 | 0.117 | 0.053 | Inosine monophosphate dehydrogenase inhibitor | 0.053 0.013 DBMET00498 | DBMET00498 | |
| 0.027 | 0.131 | 0.055 | Aconitate hydratase inhibitor | 0.055 0.031 DB11100 | DB11100 | |
| 0.024 | 0.132 | 0.043 | CC chemokine 4 receptor antagonist | 0.043 0.04 DBMET00499 | DBMET00499 | |
| 0.089 | 0.201 | 0.193 | Polo-like kinase-3 inhibitor | 0.193 0.049 DBMET00499 | DBMET00499 | |
| 0.045 | 0.158 | 0.106 | MAP-kinase-activated kinase inhibitor | 0.106 0.034 DBMET00499 | DBMET00499 | |
| 0.053 | 0.172 | 0.134 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.099 0.055 DBMET00499 0.134 0.032 DB11100 | DB11100 | |
| 0.007 | 0.126 | 0.056 | Uridine phosphorylase inhibitor | 0.033 0.015 DBMET00499 0.056 0.006 DBMET00498 0.04 0.012 DB11100 | DBMET00498 | |
| 0.034 | 0.157 | 0.073 | Sirtuin 1 inhibitor | 0.073 0.041 DBMET00499 | DBMET00499 | |
| 0.034 | 0.159 | 0.081 | Phospholipase D inhibitor | 0.073 0.048 DBMET00499 0.081 0.033 DBMET00498 | DBMET00498 | |
| 0.032 | 0.158 | 0.083 | Glutamate decarboxylase inhibitor | 0.083 0.041 DB11100 | DB11100 | |
| 0.063 | 0.19 | 0.1 | Phosphodiesterase 6D inhibitor | 0.1 0.053 DBMET00499 | DBMET00499 | |
| 0.067 | 0.198 | 0.119 | Protein kinase C nu inhibitor | 0.119 0.094 DBMET00499 | DBMET00499 | |
| 0.015 | 0.151 | 0.046 | Glutamate (mGluR3) antagonist | 0.046 0.015 DBMET00498 | DBMET00498 | |
| 0.052 | 0.189 | 0.38 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.38 0.009 DBMET00498 | DBMET00498 | |
| 0.07 | 0.21 | 0.103 | Interleukin 8 antagonist | 0.103 0.09 DBMET00499 | DBMET00499 | |
| 0.009 | 0.161 | 0.032 | Nicotinic acid receptor 2 antagonist | 0.032 0.011 DBMET00499 | DBMET00499 | |
| 0.014 | 0.168 | 0.042 | Stearoyl-CoA desaturase inhibitor | 0.042 0.033 DBMET00499 | DBMET00499 | |
| 0.032 | 0.19 | 0.083 | MAP-kinase-activated kinase 2 inhibitor | 0.083 0.041 DBMET00499 | DBMET00499 | |
| 0.029 | 0.189 | 0.062 | Dihydroorotate oxidase inhibitor | 0.062 0.026 DBMET00499 0.061 0.027 DB11100 | DBMET00499 | |
| 0.049 | 0.212 | 0.088 | Polo-like kinase-1 inhibitor | 0.088 0.065 DBMET00499 | DBMET00499 | |
| 0.02 | 0.188 | 0.076 | GABA A receptor antagonist | 0.076 0.023 DBMET00498 | DBMET00498 | |
| 0.008 | 0.178 | 0.165 | Somatostatin 4 antagonist | 0.165 0.004 DB11100 | DB11100 | |
| 0.021 | 0.191 | 0.214 | Purinergic P2 antagonist | 0.055 0.053 DBMET00499 0.214 0.006 DBMET00498 | DBMET00498 | |
| 0.01 | 0.181 | 0.126 | AMPA receptor antagonist | 0.059 0.025 DBMET00499 0.126 0.008 DBMET00498 | DBMET00498 | |
| 0.073 | 0.247 | 0.123 | Hexokinase inhibitor | 0.123 0.114 DBMET00499 | DBMET00499 | |
| 0.018 | 0.197 | 0.075 | GABA receptor antagonist | 0.075 0.024 DBMET00498 | DBMET00498 | |
| 0.027 | 0.209 | 0.063 | NMDA receptor agonist | 0.063 0.043 DB11100 | DB11100 | |
| 0.014 | 0.199 | 0.058 | Dihydroorotate dehydrogenase inhibitor | 0.058 0.03 DBMET00499 | DBMET00499 | |
| 0.016 | 0.207 | 0.073 | NMDA receptor glycine site agonist | 0.073 0.034 DB11100 | DB11100 | |
| 0.041 | 0.232 | 0.128 | Cystathionine beta-synthase inhibitor | 0.128 0.052 DBMET00498 | DBMET00498 | |
| 0.051 | 0.245 | 0.138 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.138 0.072 DBMET00499 | DBMET00499 | |
| 0.005 | 0.204 | 0.086 | Calcitonin gene-related peptide antagonist | 0.086 0.003 DBMET00499 0.066 0.005 DBMET00498 0.073 0.004 DB11100 | DBMET00499 | |
| 0.023 | 0.246 | 0.057 | I kappa B kinase 2 inhibitor | 0.057 0.054 DB11100 | DB11100 | |
| 0.078 | 0.309 | 0.421 | Prostaglandin dehydrogenase inhibitor | 0.421 0.061 DBMET00498 | DBMET00498 | |
| 0.073 | 0.308 | 0.275 | Tumour necrosis factor antagonist | 0.231 0.037 DBMET00499 0.275 0.024 DB11100 | DB11100 | |
| 0.07 | 0.305 | 0.429 | Growth hormone agonist | 0.204 0.057 DBMET00499 0.429 0.012 DB11100 | DB11100 | |
| 0.005 | 0.246 | 0.118 | Calcitonin gene-related peptide 1 receptor antagonist | 0.118 0.003 DBMET00499 0.115 0.004 DBMET00498 0.114 0.004 DB11100 | DBMET00499 | |
| 0.057 | 0.308 | 0.146 | Mannose-6-phosphate isomerase inhibitor | 0.146 0.068 DBMET00498 | DBMET00498 | |
| 0.005 | 0.262 | 0.208 | Somatostatin 2 antagonist | 0.208 0.004 DB11100 | DB11100 | |
| 0.019 | 0.28 | 0.137 | NMDA receptor antagonist | 0.137 0.029 DBMET00498 | DBMET00498 | |
| 0.007 | 0.284 | 0.088 | Purinergic P2Y antagonist | 0.052 0.025 DBMET00499 0.088 0.011 DBMET00498 | DBMET00498 | |
| 0.076 | 0.355 | 0.123 | Sphingosine 1-phosphate receptor 5 antagonist | 0.123 0.118 DBMET00498 | DBMET00498 | |
| 0.005 | 0.298 | 0.041 | NMDA receptor subunit 3A antagonist | 0.041 0.024 DBMET00498 | DBMET00498 | |
| 0.045 | 0.339 | 0.313 | Anesthetic general | 0.135 0.131 DBMET00499 0.313 0.03 DB11100 | DB11100 | |
| 0.023 | 0.329 | 0.064 | Glucosylceramidase inhibitor | 0.064 0.026 DBMET00498 | DBMET00498 | |
| 0.05 | 0.36 | 0.23 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.23 0.085 DBMET00498 | DBMET00498 | |
| 0.028 | 0.34 | 0.515 | Keratolytic | 0.515 0.002 DB11100 | DB11100 | |
| 0.007 | 0.341 | 0.062 | NMDA receptor subunit 3B antagonist | 0.062 0.018 DBMET00498 | DBMET00498 | |
| 0.008 | 0.35 | 0.033 | Somatostatin agonist | 0.033 0.021 DB11100 | DB11100 | |
| 0.075 | 0.424 | 0.324 | Gastrin inhibitor | 0.324 0.019 DB11100 | DB11100 | |
| 0.07 | 0.43 | 0.351 | 15-Lipoxygenase inhibitor | 0.351 0.099 DBMET00498 | DBMET00498 | |
| 0.055 | 0.43 | 0.31 | DNA polymerase beta inhibitor | 0.31 0.16 DBMET00498 | DBMET00498 | |
| 0.031 | 0.407 | 0.086 | Bromodomain-containing protein 2 inhibitor | 0.086 0.064 DBMET00499 0.08 0.076 DB11100 | DBMET00499 | |
| 0.052 | 0.436 | 0.186 | Thyroid hormone antagonist | 0.186 0.174 DBMET00498 | DBMET00498 | |
| 0.051 | 0.446 | 0.41 | Cardiotonic | 0.41 0.027 DBMET00499 0.215 0.106 DB11100 | DBMET00499 | |
| 0.007 | 0.406 | 0.06 | Somatostatin 1 antagonist | 0.06 0.015 DB11100 | DB11100 | |
| 0.004 | 0.41 | 0.672 | Purinergic P2Y12 antagonist | 0.055 0.006 DBMET00499 0.672 0.002 DBMET00498 | DBMET00498 | |
| 0.05 | 0.458 | 0.178 | Thyroid hormone beta antagonist | 0.178 0.175 DBMET00498 | DBMET00498 | |
| 0.005 | 0.414 | 0.08 | Nicotinic acid receptor 2 agonist | 0.08 0.008 DBMET00499 | DBMET00499 | |
| 0.022 | 0.446 | 0.148 | AMP-activated protein kinase stimulant | 0.148 0.029 DBMET00498 | DBMET00498 | |
| 0.005 | 0.435 | 0.089 | Somatostatin 3 antagonist | 0.089 0.004 DB11100 | DB11100 | |
| 0.034 | 0.473 | 0.17 | Platelet aggregation inhibitor | 0.17 0.107 DBMET00499 | DBMET00499 | |
| 0.032 | 0.472 | 0.245 | Interleukin antagonist | 0.245 0.064 DBMET00498 | DBMET00498 | |
| 0.017 | 0.462 | 0.086 | Caspase 7 inhibitor | 0.086 0.049 DBMET00498 | DBMET00498 | |
| 0.083 | 0.574 | 0.26 | Peptidyltransferase inhibitor | 0.26 0.044 DBMET00499 0.24 0.058 DB11100 | DBMET00499 | |
| 0.018 | 0.522 | 0.333 | Somatostatin 1 agonist | 0.333 0.002 DB11100 | DB11100 | |
| 0.026 | 0.558 | 0.165 | Interleukin 5 antagonist | 0.165 0.008 DBMET00498 | DBMET00498 | |
| 0.03 | 0.597 | 0.565 | Interleukin 4 antagonist | 0.565 0.004 DBMET00498 | DBMET00498 | |
| 0.008 | 0.608 | 0.188 | Glutamate receptor antagonist | 0.188 0.03 DBMET00498 | DBMET00498 | |
| 0.021 | 0.628 | 0.115 | Interleukin 1 antagonist | 0.115 0.096 DBMET00498 | DBMET00498 | |
| 0.013 | 0.654 | 0.248 | Alpha-glucosidase inhibitor | 0.248 0.188 DBMET00498 | DBMET00498 | |
| 0.003 | 0.665 | 0.027 | Kainate receptor 4 antagonist | 0.027 0.016 DBMET00498 | DBMET00498 | |
| 0.002 | 0.777 | 0.909 | Cholecystokinin B antagonist | 0.909 0.001 DB11100 | DB11100 | |
| 0.003 | 0.796 | 0.925 | Cholecystokinin A antagonist | 0.925 0.001 DB11100 | DB11100 | |
| 0.006 | 0.806 | 0.314 | Potassium channel blocker | 0.314 0.042 DB11100 | DB11100 | |
| 0.003 | 0.863 | 0.946 | Cholecystokinin antagonist | 0.946 0.001 DB11100 | DB11100 | |
| 0.007 | 0.869 | 0.31 | Streptokinase A inhibitor | 0.31 0.075 DBMET00498 | DBMET00498 | |
| 0.004 | 0.867 | 0.047 | Bromodomain-containing protein 3 inhibitor | 0.047 0.039 DB11100 | DB11100 | |
| 0.002 | 0.878 | 0.015 | Thyroid hormone alpha agonist | 0.015 0.014 DB11100 | DB11100 | |
| 0.008 | 0.893 | 0.142 | Interleukin 6 antagonist | 0.142 0.101 DB11100 | DB11100 | |
| 0.005 | 0.897 | 0.113 | M17 leucyl aminopeptidase inhibitor | 0.113 0.084 DBMET00498 | DBMET00498 | |
| 0.004 | 0.918 | 0.06 | Mineralocorticoid receptor antagonist | 0.06 0.02 DB11100 | DB11100 | |
| 0.002 | 0.919 | 0.048 | Somatostatin 5 antagonist | 0.048 0.014 DB11100 | DB11100 | |
| 0.005 | 0.922 | 0.367 | Thioredoxin glutathione reductase inhibitor | 0.367 0.07 DBMET00498 | DBMET00498 | |
| 0.002 | 0.932 | 0.049 | Cholecystokinin agonist | 0.049 0.007 DB11100 | DB11100 | |
| 0.002 | 0.948 | 0.033 | Bradykinin antagonist | 0.033 0.032 DB11100 | DB11100 | |
| 0.01 | 0.984 | 0.191 | Heme oxygenase stimulant | 0.191 0.002 DBMET00498 | DBMET00498 | |
| 0.002 | 0.977 | 0.054 | Kinesin antagonist | 0.054 0.015 DB11100 | DB11100 | |
| 0.002 | 0.977 | 0.054 | Kinesin-like protein 1 inhibitor | 0.054 0.015 DB11100 | DB11100 | |
| 0.004 | 0.984 | 0.369 | Antiobesity | 0.369 0.078 DB11100 | DB11100 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |